Benefits Of Polio Vaccine

Benefits Of Polio Vaccine: At one point in American history, polio was the most common cause of disability among American children. polio has been eliminated in the United States that since introduction of a vaccination in 1955. It’s possible that the illness might still spread to the United States if it’s still prevalent in underdeveloped nations. As a result, the polio vaccine is still included in the list of recommended vaccinations for children. Before a kid may enter school, they must usually be immunised against polio in most regions of the United States.

Methods Of Giving The Polio Vaccine

Benefits Of Polio Vaccine: Prior to the year 2000, oral polio vaccine (OPV), manufactured from a live poliovirus, may have been used to immunise against polio. E ven though live virus vaccination was very efficient in guarding against polio, a few instances of polio each year were produced by oral vaccine itself. The inactive polio vaccine was introduced in the United States in 2000. The IPV is delivered as an injection in the arm or leg to use an inactive (dead) version of the virus that really can cause polio.

Do People Really Need To Get The Polio Vaccine?

The polio vaccination should be given to the majority of children. At the following ages, children should get IPV vaccinations consisting of four doses:

  • A dosage after two months
  • A dosage after four months
  • Taken every 6-18 months
  • A booster dose forĀ  4 to 6 years

At the same time as you get other vaccines, IPV may be given

Adults in the United States over the age of 18 are not recommended to have a regular polio immunization because of the high proportion of adults who had the vaccine as children. However, three categories of individuals who are more risk to the polio virus should be vaccinated.


  • Travelers to countries where polio is prevalent
  • A laboratory worker who handles poliovirus specimens.
  • People who come into close touch with someone who may be infected with poliovirus.

To Whom The Polio Vaccine Should Not Be Given?

The polio vaccination is not recommended for the people, if any of the following applies:

As of 2016, all OPVs are quite affordable (US $0.12 to $0.18 for countries purchasing via UNICEF).

OPVs are effective and safe, and they provide long-term protection from the serotype(s) they target. OPV’s ability to halt the spread of the virus is due to its ability to boost mucosal immunity.

OPVs are given orally & do not need the use of sterilised needle syringes or medical personnel. To administer in large immunisation programmes, OPVs are simple.

Excessive excretion and close contact with others may transmit the vaccine virus for many weeks after immunisation. As a consequence, OPV vaccination may result in ‘passive’ immunisation of persons who have not yet been vaccinated in locations with inadequate hygiene and sanitation conditions.

In the past, the polio vaccination caused an allergic response that was too severe for you to handle.

Strepsimycin, polymyxin B, and neomycin caused a serious allergic response for you

The vaccination has been shown to be safe for pregnant women, although pregnant women must avoid it if at all feasible. Expectant adults in any of the categories described above should talk to their physicians about getting an IPV on the schedule advised for adults..

Those who have been unwell for a significant amount of time should wait until they are well enough to get the vaccination.

Polio Vaccination Risks And Consequences

Benefits Of Polio Vaccine: The polio vaccination may cause a painful, red patch on the arm or leg of those who get it, but other than that, the vaccine is completely safe. For the most part, this isn’t an issue for anybody.

A severe allergic response might occur as a result of the polio vaccination, just like any other drug. The vaccination has a very low chance of causing major side effects.

There are no known side effects from OPV. OPV’s live attenuated vaccine-virus may, in rare occasions (about 2 to 4 incidents per 1 million births [1]), cause paralysis. In certain circumstances, an immunodeficiency may be to blame for this. Most public health programmers recognize the modest risk of vaccine-associated paralytic poliomyelitis (VAPP).

Occasionally, a vaccine-virus could be able to spread, mutate, and reacquire neurovirulence over the span of 12 to 18 months in a population with low vaccination rates. A circulation of vaccine-derived poliovirus is what this is.

Leave a Reply

Your email address will not be published. Required fields are marked *